Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA” New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovation GlobeNewswire January 09, 2026 BOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a […]

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium GlobeNewswire January 09, 2026 Updated interim results with an additional ~13 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Updated efficacy analysis suggests durable disease control and deepening of

H&R Block Tax Pro Review Free for New Clients with Purchase of DIY Products Elevating the digital-first experience for consumers, powered by H&R Block's tax professional expertise GlobeNewswire January 09, 2026 KANSAS CITY, Mo., Jan. 09, 2026 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) today announced it will include Tax Pro Review services at no

iHerb Strengthens Growing Domestic Business with Acquisition of Vitacost from Kroger Strategic Transaction Accelerates iHerb's U.S. Business and Solidifies Commitment to the Vitamins, Minerals and Supplements Category GlobeNewswire January 09, 2026 IRVINE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — iHerb Holdings, LLC, one of the world's largest online retailers specializing in health and wellness, today

Mutuum Finance's Phase 7 is Surging as MUTM Growth Exceeds 300% Growth Since 2025 GlobeNewswire January 09, 2026 DUBAI, United Arab Emirates, Jan. 09, 2026 (GLOBE NEWSWIRE) — Presales rarely stay quiet once momentum builds. When demand keeps rising across multiple stages, later phases tend to move faster and attract more attention. That is exactly

Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026 GlobeNewswire January 09, 2026 TALLAHASSEE, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) — Capital City Bank Group, Inc. (NASDAQ: CCBG) announced today that it will release fourth quarter and year-end 2025 results on Tuesday, January 27, 2026, before the market opens.

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco GlobeNewswire January 09, 2026 BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces

Avance Clinical to Showcase New Early Phase Center of Excellence at Biotech Showcase 2026 GlobeNewswire January 09, 2026 ADELAIDE, Australia, Jan. 09, 2026 (GLOBE NEWSWIRE) — Avance Clinical, the award-winning Australian led, global CRO built exclusively to service the clinical research needs of biotech companies, announced today that its executive team will attend Biotech Showcase

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 09, 2026 Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US community and global market penetration Enrolling three Phase 3 trials across multiple melanoma indications

Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes GlobeNewswire January 09, 2026 PRESS RELEASE Memo Therapeutics AG Publishes BKPyV Infection Disease Burden Study in the Journal of Patient-Reported Outcomes First conceptual model demonstrating the impact of BK polyomavirus on the health-related quality of life of kidney transplant recipients